Krystal Biotech, Inc. KRYS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $204.83M+130% | $89.16M+716% | $10.93M+108% | -$139.98M-101% | ||
| $5.67M-3.7% | $5.89M+6.3% | $5.54M+36.7% | $4.06M+46.4% | ||
| $54.51M+11.0% | $49.13M+23.0% | $39.93M+20.2% | $33.23M+117% | ||
| $200.87M+57.4% | $127.59M+244% | -$88.8M+11.7% | -$100.57M-110% | ||
| $11.95M+182% | $4.24M-64.1% | $11.8M-77.7% | $52.98M-22.5% | ||
| —— | -$163.44M— | —— | -$114.08M+49.7% | ||
| —— | $27.01M-86.7% | $202.75M+474% | $35.35M-89.8% | ||
| $151.44M+1,225% | -$13.46M-106% | $211.34M+218% | -$179.35M— | ||
| $188.91M+51.8% | $124.48M+224% | -$100.6M+34.5% | -$153.55M-32.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Krystal Biotech, Inc. generate?
- Krystal Biotech, Inc. (KRYS) generated $250.3M in operating cash flow over the trailing twelve months.
- What is Krystal Biotech, Inc.'s free cash flow?
- After $12.9M of capital expenditures, Krystal Biotech, Inc.'s free cash flow was $237.4M over the trailing twelve months, up 76.3% year over year.
- Where does Krystal Biotech, Inc.'s cash flow data come from?
- Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
